title: Influence of cladribine alone and in combination with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia.
authors.forename: Anna
authors.initials: A
authors.lastname: Szmigielska-Kapłon
authors.forename: Dorota
authors.initials: D
authors.lastname: Jesionek-Kupnicka
authors.forename: Joanna
authors.initials: J
authors.lastname: Góra-Tybor
authors.forename: Jerzy Z
authors.initials: JZ
authors.lastname: Błonski
authors.forename: Ewa
authors.initials: E
authors.lastname: Lech-Marańda
authors.forename: Radzisław
authors.initials: R
authors.lastname: Kordek
authors.forename: Marek
authors.initials: M
authors.lastname: Kasznicki
authors.forename: Tadeusz
authors.initials: T
authors.lastname: Robak
mesh_terms: D000328:Adult; D000368:Aged; D001854:Bone Marrow Cells / Q000187:drug effects* / Q000473:pathology; D017338:Cladribine / Q000008:administration & dosage* / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage*; D009389:Neovascularization, Pathologic; D016896:Treatment Outcome
chemical_list: D017338:Cladribine; D003520:Cyclophosphamide; D008942:Mitoxantrone